IAS
IMA Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-19,776
| Closed | -$778K | – | 341 |
|
|
2024
Q4 | $778K | Sell |
19,776
-750
| -4% | -$29.5K | 0.09% | 130 |
|
|
2024
Q3 | $964K | Sell |
20,526
-2,922
| -12% | -$137K | 0.21% | 99 |
|
|
2024
Q2 | $1.27M | Sell |
23,448
-538
| -2% | -$29.1K | 0.56% | 52 |
|
|
2024
Q1 | $1.63M | Sell |
23,986
-695
| -3% | -$47.4K | 0.77% | 42 |
|
|
2023
Q4 | $1.55M | Sell |
24,681
-836
| -3% | -$52.3K | 0.77% | 42 |
|
|
2023
Q3 | $1.16M | Sell |
25,517
-255
| -1% | -$11.6K | 0.3% | 83 |
|
|
2023
Q2 | $1.45M | Buy |
25,772
+710
| +3% | +$39.9K | 0.37% | 78 |
|
|
2023
Q1 | $1.13M | Sell |
25,062
-569
| -2% | -$25.7K | 0.29% | 86 |
|
|
2022
Q4 | $1.04M | Sell |
25,631
-1,037
| -4% | -$42.2K | 0.28% | 87 |
|
|
2022
Q3 | $1.74M | Sell |
26,668
-1,227
| -4% | -$80.2K | 0.47% | 63 |
|
|
2022
Q2 | $1.7M | Sell |
27,895
-84
| -0.3% | -$5.1K | 0.41% | 75 |
|
|
2022
Q1 | $1.76M | Buy |
27,979
+3,327
| +13% | +$209K | 0.4% | 81 |
|
|
2021
Q4 | $1.87M | Buy |
24,652
+1,148
| +5% | +$87K | 0.41% | 80 |
|
|
2021
Q3 | $2.63M | Buy |
23,504
+221
| +0.9% | +$24.7K | 0.62% | 55 |
|
|
2021
Q2 | $3.77M | Sell |
23,283
-2,980
| -11% | -$482K | 0.88% | 29 |
|
|
2021
Q1 | $3.2M | Buy |
26,263
+3,349
| +15% | +$408K | 0.78% | 41 |
|
|
2020
Q4 | $3.51M | Sell |
22,914
-892
| -4% | -$137K | 0.98% | 27 |
|
|
2020
Q3 | $1.99M | Sell |
23,806
-14,447
| -38% | -$1.21M | 0.67% | 51 |
|
|
2020
Q2 | $2.81M | Sell |
38,253
-91
| -0.2% | -$6.69K | 1.02% | 31 |
|
|
2020
Q1 | $1.63M | Buy |
+38,344
| New | +$1.63M | 0.72% | 52 |
|